カテゴリ： Market Monitor Global, 世界, 医療/バイオ

チップ用抗体のグローバル市場展望 2023年-2029年：モノクローナル抗体、ポリクローナル抗体

■ 英語タイトル：Chip Grade Antibodies Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC12773）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC12773
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：72
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[チップ用抗体のグローバル市場展望 2023年-2029年：モノクローナル抗体、ポリクローナル抗体]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のチップ用抗体市場規模と予測を収録しています。・世界のチップ用抗体市場：売上、2018年-2023年、2024年-2029年
・世界のチップ用抗体市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のチップ用抗体市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「モノクローナル抗体」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

チップ用抗体のグローバル主要企業は、Cusabio、 Merck KGaA、 BioLegend、 Abcam、 Santa Cruz Biotechnology, Inc.、 Abiocode、 Thermo Fisher Scientificなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、チップ用抗体のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のチップ用抗体市場：タイプ別、2018年-2023年、2024年-2029年
世界のチップ用抗体市場：タイプ別市場シェア、2022年
・モノクローナル抗体、ポリクローナル抗体

世界のチップ用抗体市場：用途別、2018年-2023年、2024年-2029年
世界のチップ用抗体市場：用途別市場シェア、2022年
・医療診断、食品&飲料、医薬品研究開発、その他

世界のチップ用抗体市場：地域・国別、2018年-2023年、2024年-2029年
世界のチップ用抗体市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるチップ用抗体のグローバル売上、2018年-2023年
・主要企業におけるチップ用抗体のグローバル売上シェア、2022年
・主要企業におけるチップ用抗体のグローバル販売量、2018年-2023年
・主要企業におけるチップ用抗体のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Cusabio、 Merck KGaA、 BioLegend、 Abcam、 Santa Cruz Biotechnology, Inc.、 Abiocode、 Thermo Fisher Scientific

*************************************************************

・調査・分析レポートの概要
チップ用抗体市場の定義
市場セグメント
世界のチップ用抗体市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のチップ用抗体市場規模
世界のチップ用抗体市場規模：2022年 VS 2029年
世界のチップ用抗体市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのチップ用抗体の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のチップ用抗体製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：モノクローナル抗体、ポリクローナル抗体
チップ用抗体のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：医療診断、食品&飲料、医薬品研究開発、その他
チップ用抗体の用途別グローバル売上・予測

・地域別市場分析
地域別チップ用抗体市場規模 2022年と2029年
地域別チップ用抗体売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Cusabio、 Merck KGaA、 BioLegend、 Abcam、 Santa Cruz Biotechnology, Inc.、 Abiocode、 Thermo Fisher Scientific
...

This research report provides a comprehensive analysis of the Chip Grade Antibodies market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Chip Grade Antibodies market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Chip Grade Antibodies, challenges faced by the industry, and potential opportunities for market players.
The global Chip Grade Antibodies market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Chip Grade Antibodies market presents opportunities for various stakeholders, including Medical Diagnosis, Food & Beverage. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Chip Grade Antibodies market. Additionally, the growing consumer demand present avenues for market expansion.
The global Chip Grade Antibodies market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Chip Grade Antibodies market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Chip Grade Antibodies market.
Market Overview: The report provides a comprehensive overview of the Chip Grade Antibodies market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Monoclonal Antibodies, Polyclonal Antibodies), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Chip Grade Antibodies market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Chip Grade Antibodies market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Chip Grade Antibodies market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Chip Grade Antibodies market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Chip Grade Antibodies market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Chip Grade Antibodies market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Chip Grade Antibodies, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Chip Grade Antibodies market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Chip Grade Antibodies market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Monoclonal Antibodies
Polyclonal Antibodies
Market segment by Application
Medical Diagnosis
Food & Beverage
Drug Research & Development
Others
Global Chip Grade Antibodies Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Cusabio
Merck KGaA
BioLegend
Abcam
Santa Cruz Biotechnology, Inc.
Abiocode
Thermo Fisher Scientific
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chip Grade Antibodies, market overview.
Chapter 2: Global Chip Grade Antibodies market size in revenue and volume.
Chapter 3: Detailed analysis of Chip Grade Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chip Grade Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Chip Grade Antibodies capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Chip Grade Antibodies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chip Grade Antibodies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chip Grade Antibodies Overall Market Size
2.1 Global Chip Grade Antibodies Market Size: 2022 VS 2029
2.2 Global Chip Grade Antibodies Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Chip Grade Antibodies Sales: 2018-2029
3 Company Landscape
3.1 Top Chip Grade Antibodies Players in Global Market
3.2 Top Global Chip Grade Antibodies Companies Ranked by Revenue
3.3 Global Chip Grade Antibodies Revenue by Companies
3.4 Global Chip Grade Antibodies Sales by Companies
3.5 Global Chip Grade Antibodies Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Chip Grade Antibodies Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Chip Grade Antibodies Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chip Grade Antibodies Players in Global Market
3.8.1 List of Global Tier 1 Chip Grade Antibodies Companies
3.8.2 List of Global Tier 2 and Tier 3 Chip Grade Antibodies Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Chip Grade Antibodies Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 Polyclonal Antibodies
4.2 By Type – Global Chip Grade Antibodies Revenue & Forecasts
4.2.1 By Type – Global Chip Grade Antibodies Revenue, 2018-2023
4.2.2 By Type – Global Chip Grade Antibodies Revenue, 2024-2029
4.2.3 By Type – Global Chip Grade Antibodies Revenue Market Share, 2018-2029
4.3 By Type – Global Chip Grade Antibodies Sales & Forecasts
4.3.1 By Type – Global Chip Grade Antibodies Sales, 2018-2023
4.3.2 By Type – Global Chip Grade Antibodies Sales, 2024-2029
4.3.3 By Type – Global Chip Grade Antibodies Sales Market Share, 2018-2029
4.4 By Type – Global Chip Grade Antibodies Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Chip Grade Antibodies Market Size, 2022 & 2029
5.1.2 Medical Diagnosis
5.1.3 Food & Beverage
5.1.4 Drug Research & Development
5.1.5 Others
5.2 By Application – Global Chip Grade Antibodies Revenue & Forecasts
5.2.1 By Application – Global Chip Grade Antibodies Revenue, 2018-2023
5.2.2 By Application – Global Chip Grade Antibodies Revenue, 2024-2029
5.2.3 By Application – Global Chip Grade Antibodies Revenue Market Share, 2018-2029
5.3 By Application – Global Chip Grade Antibodies Sales & Forecasts
5.3.1 By Application – Global Chip Grade Antibodies Sales, 2018-2023
5.3.2 By Application – Global Chip Grade Antibodies Sales, 2024-2029
5.3.3 By Application – Global Chip Grade Antibodies Sales Market Share, 2018-2029
5.4 By Application – Global Chip Grade Antibodies Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Chip Grade Antibodies Market Size, 2022 & 2029
6.2 By Region – Global Chip Grade Antibodies Revenue & Forecasts
6.2.1 By Region – Global Chip Grade Antibodies Revenue, 2018-2023
6.2.2 By Region – Global Chip Grade Antibodies Revenue, 2024-2029
6.2.3 By Region – Global Chip Grade Antibodies Revenue Market Share, 2018-2029
6.3 By Region – Global Chip Grade Antibodies Sales & Forecasts
6.3.1 By Region – Global Chip Grade Antibodies Sales, 2018-2023
6.3.2 By Region – Global Chip Grade Antibodies Sales, 2024-2029
6.3.3 By Region – Global Chip Grade Antibodies Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Chip Grade Antibodies Revenue, 2018-2029
6.4.2 By Country – North America Chip Grade Antibodies Sales, 2018-2029
6.4.3 US Chip Grade Antibodies Market Size, 2018-2029
6.4.4 Canada Chip Grade Antibodies Market Size, 2018-2029
6.4.5 Mexico Chip Grade Antibodies Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Chip Grade Antibodies Revenue, 2018-2029
6.5.2 By Country – Europe Chip Grade Antibodies Sales, 2018-2029
6.5.3 Germany Chip Grade Antibodies Market Size, 2018-2029
6.5.4 France Chip Grade Antibodies Market Size, 2018-2029
6.5.5 U.K. Chip Grade Antibodies Market Size, 2018-2029
6.5.6 Italy Chip Grade Antibodies Market Size, 2018-2029
6.5.7 Russia Chip Grade Antibodies Market Size, 2018-2029
6.5.8 Nordic Countries Chip Grade Antibodies Market Size, 2018-2029
6.5.9 Benelux Chip Grade Antibodies Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Chip Grade Antibodies Revenue, 2018-2029
6.6.2 By Region – Asia Chip Grade Antibodies Sales, 2018-2029
6.6.3 China Chip Grade Antibodies Market Size, 2018-2029
6.6.4 Japan Chip Grade Antibodies Market Size, 2018-2029
6.6.5 South Korea Chip Grade Antibodies Market Size, 2018-2029
6.6.6 Southeast Asia Chip Grade Antibodies Market Size, 2018-2029
6.6.7 India Chip Grade Antibodies Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Chip Grade Antibodies Revenue, 2018-2029
6.7.2 By Country – South America Chip Grade Antibodies Sales, 2018-2029
6.7.3 Brazil Chip Grade Antibodies Market Size, 2018-2029
6.7.4 Argentina Chip Grade Antibodies Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Chip Grade Antibodies Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Chip Grade Antibodies Sales, 2018-2029
6.8.3 Turkey Chip Grade Antibodies Market Size, 2018-2029
6.8.4 Israel Chip Grade Antibodies Market Size, 2018-2029
6.8.5 Saudi Arabia Chip Grade Antibodies Market Size, 2018-2029
6.8.6 UAE Chip Grade Antibodies Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Cusabio
7.1.1 Cusabio Company Summary
7.1.2 Cusabio Business Overview
7.1.3 Cusabio Chip Grade Antibodies Major Product Offerings
7.1.4 Cusabio Chip Grade Antibodies Sales and Revenue in Global (2018-2023)
7.1.5 Cusabio Key News & Latest Developments
7.2 Merck KGaA
7.2.1 Merck KGaA Company Summary
7.2.2 Merck KGaA Business Overview
7.2.3 Merck KGaA Chip Grade Antibodies Major Product Offerings
7.2.4 Merck KGaA Chip Grade Antibodies Sales and Revenue in Global (2018-2023)
7.2.5 Merck KGaA Key News & Latest Developments
7.3 BioLegend
7.3.1 BioLegend Company Summary
7.3.2 BioLegend Business Overview
7.3.3 BioLegend Chip Grade Antibodies Major Product Offerings
7.3.4 BioLegend Chip Grade Antibodies Sales and Revenue in Global (2018-2023)
7.3.5 BioLegend Key News & Latest Developments
7.4 Abcam
7.4.1 Abcam Company Summary
7.4.2 Abcam Business Overview
7.4.3 Abcam Chip Grade Antibodies Major Product Offerings
7.4.4 Abcam Chip Grade Antibodies Sales and Revenue in Global (2018-2023)
7.4.5 Abcam Key News & Latest Developments
7.5 Santa Cruz Biotechnology, Inc.
7.5.1 Santa Cruz Biotechnology, Inc. Company Summary
7.5.2 Santa Cruz Biotechnology, Inc. Business Overview
7.5.3 Santa Cruz Biotechnology, Inc. Chip Grade Antibodies Major Product Offerings
7.5.4 Santa Cruz Biotechnology, Inc. Chip Grade Antibodies Sales and Revenue in Global (2018-2023)
7.5.5 Santa Cruz Biotechnology, Inc. Key News & Latest Developments
7.6 Abiocode
7.6.1 Abiocode Company Summary
7.6.2 Abiocode Business Overview
7.6.3 Abiocode Chip Grade Antibodies Major Product Offerings
7.6.4 Abiocode Chip Grade Antibodies Sales and Revenue in Global (2018-2023)
7.6.5 Abiocode Key News & Latest Developments
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Company Summary
7.7.2 Thermo Fisher Scientific Business Overview
7.7.3 Thermo Fisher Scientific Chip Grade Antibodies Major Product Offerings
7.7.4 Thermo Fisher Scientific Chip Grade Antibodies Sales and Revenue in Global (2018-2023)
7.7.5 Thermo Fisher Scientific Key News & Latest Developments
8 Global Chip Grade Antibodies Production Capacity, Analysis
8.1 Global Chip Grade Antibodies Production Capacity, 2018-2029
8.2 Chip Grade Antibodies Production Capacity of Key Manufacturers in Global Market
8.3 Global Chip Grade Antibodies Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chip Grade Antibodies Supply Chain Analysis
10.1 Chip Grade Antibodies Industry Value Chain
10.2 Chip Grade Antibodies Upstream Market
10.3 Chip Grade Antibodies Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chip Grade Antibodies Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Chip Grade Antibodies in Global Market
Table 2. Top Chip Grade Antibodies Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Chip Grade Antibodies Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Chip Grade Antibodies Revenue Share by Companies, 2018-2023
Table 5. Global Chip Grade Antibodies Sales by Companies, (Kg), 2018-2023
Table 6. Global Chip Grade Antibodies Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Chip Grade Antibodies Price (2018-2023) & (US$/Kg)
Table 8. Global Manufacturers Chip Grade Antibodies Product Type
Table 9. List of Global Tier 1 Chip Grade Antibodies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chip Grade Antibodies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Chip Grade Antibodies Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Chip Grade Antibodies Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Chip Grade Antibodies Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Chip Grade Antibodies Sales (Kg), 2018-2023
Table 15. By Type - Global Chip Grade Antibodies Sales (Kg), 2024-2029
Table 16. By Application – Global Chip Grade Antibodies Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Chip Grade Antibodies Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Chip Grade Antibodies Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Chip Grade Antibodies Sales (Kg), 2018-2023
Table 20. By Application - Global Chip Grade Antibodies Sales (Kg), 2024-2029
Table 21. By Region – Global Chip Grade Antibodies Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Chip Grade Antibodies Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Chip Grade Antibodies Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Chip Grade Antibodies Sales (Kg), 2018-2023
Table 25. By Region - Global Chip Grade Antibodies Sales (Kg), 2024-2029
Table 26. By Country - North America Chip Grade Antibodies Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Chip Grade Antibodies Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Chip Grade Antibodies Sales, (Kg), 2018-2023
Table 29. By Country - North America Chip Grade Antibodies Sales, (Kg), 2024-2029
Table 30. By Country - Europe Chip Grade Antibodies Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Chip Grade Antibodies Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Chip Grade Antibodies Sales, (Kg), 2018-2023
Table 33. By Country - Europe Chip Grade Antibodies Sales, (Kg), 2024-2029
Table 34. By Region - Asia Chip Grade Antibodies Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Chip Grade Antibodies Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Chip Grade Antibodies Sales, (Kg), 2018-2023
Table 37. By Region - Asia Chip Grade Antibodies Sales, (Kg), 2024-2029
Table 38. By Country - South America Chip Grade Antibodies Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Chip Grade Antibodies Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Chip Grade Antibodies Sales, (Kg), 2018-2023
Table 41. By Country - South America Chip Grade Antibodies Sales, (Kg), 2024-2029
Table 42. By Country - Middle East & Africa Chip Grade Antibodies Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Chip Grade Antibodies Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Chip Grade Antibodies Sales, (Kg), 2018-2023
Table 45. By Country - Middle East & Africa Chip Grade Antibodies Sales, (Kg), 2024-2029
Table 46. Cusabio Company Summary
Table 47. Cusabio Chip Grade Antibodies Product Offerings
Table 48. Cusabio Chip Grade Antibodies Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 49. Cusabio Key News & Latest Developments
Table 50. Merck KGaA Company Summary
Table 51. Merck KGaA Chip Grade Antibodies Product Offerings
Table 52. Merck KGaA Chip Grade Antibodies Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 53. Merck KGaA Key News & Latest Developments
Table 54. BioLegend Company Summary
Table 55. BioLegend Chip Grade Antibodies Product Offerings
Table 56. BioLegend Chip Grade Antibodies Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 57. BioLegend Key News & Latest Developments
Table 58. Abcam Company Summary
Table 59. Abcam Chip Grade Antibodies Product Offerings
Table 60. Abcam Chip Grade Antibodies Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 61. Abcam Key News & Latest Developments
Table 62. Santa Cruz Biotechnology, Inc. Company Summary
Table 63. Santa Cruz Biotechnology, Inc. Chip Grade Antibodies Product Offerings
Table 64. Santa Cruz Biotechnology, Inc. Chip Grade Antibodies Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 65. Santa Cruz Biotechnology, Inc. Key News & Latest Developments
Table 66. Abiocode Company Summary
Table 67. Abiocode Chip Grade Antibodies Product Offerings
Table 68. Abiocode Chip Grade Antibodies Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 69. Abiocode Key News & Latest Developments
Table 70. Thermo Fisher Scientific Company Summary
Table 71. Thermo Fisher Scientific Chip Grade Antibodies Product Offerings
Table 72. Thermo Fisher Scientific Chip Grade Antibodies Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 73. Thermo Fisher Scientific Key News & Latest Developments
Table 74. Chip Grade Antibodies Production Capacity (Kg) of Key Manufacturers in Global Market, 2021-2023 (Kg)
Table 75. Global Chip Grade Antibodies Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Chip Grade Antibodies Production by Region, 2018-2023 (Kg)
Table 77. Global Chip Grade Antibodies Production by Region, 2024-2029 (Kg)
Table 78. Chip Grade Antibodies Market Opportunities & Trends in Global Market
Table 79. Chip Grade Antibodies Market Drivers in Global Market
Table 80. Chip Grade Antibodies Market Restraints in Global Market
Table 81. Chip Grade Antibodies Raw Materials
Table 82. Chip Grade Antibodies Raw Materials Suppliers in Global Market
Table 83. Typical Chip Grade Antibodies Downstream
Table 84. Chip Grade Antibodies Downstream Clients in Global Market
Table 85. Chip Grade Antibodies Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Chip Grade Antibodies Segment by Type in 2022
Figure 2. Chip Grade Antibodies Segment by Application in 2022
Figure 3. Global Chip Grade Antibodies Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chip Grade Antibodies Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Chip Grade Antibodies Revenue, 2018-2029 (US$, Mn)
Figure 7. Chip Grade Antibodies Sales in Global Market: 2018-2029 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Chip Grade Antibodies Revenue in 2022
Figure 9. By Type - Global Chip Grade Antibodies Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Chip Grade Antibodies Revenue Market Share, 2018-2029
Figure 11. By Type - Global Chip Grade Antibodies Sales Market Share, 2018-2029
Figure 12. By Type - Global Chip Grade Antibodies Price (US$/Kg), 2018-2029
Figure 13. By Application - Global Chip Grade Antibodies Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Chip Grade Antibodies Revenue Market Share, 2018-2029
Figure 15. By Application - Global Chip Grade Antibodies Sales Market Share, 2018-2029
Figure 16. By Application - Global Chip Grade Antibodies Price (US$/Kg), 2018-2029
Figure 17. By Region - Global Chip Grade Antibodies Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Chip Grade Antibodies Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Chip Grade Antibodies Revenue Market Share, 2018-2029
Figure 20. By Region - Global Chip Grade Antibodies Sales Market Share, 2018-2029
Figure 21. By Country - North America Chip Grade Antibodies Revenue Market Share, 2018-2029
Figure 22. By Country - North America Chip Grade Antibodies Sales Market Share, 2018-2029
Figure 23. US Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Chip Grade Antibodies Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Chip Grade Antibodies Sales Market Share, 2018-2029
Figure 28. Germany Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 29. France Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Chip Grade Antibodies Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Chip Grade Antibodies Sales Market Share, 2018-2029
Figure 37. China Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 41. India Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Chip Grade Antibodies Revenue Market Share, 2018-2029
Figure 43. By Country - South America Chip Grade Antibodies Sales Market Share, 2018-2029
Figure 44. Brazil Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Chip Grade Antibodies Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Chip Grade Antibodies Sales Market Share, 2018-2029
Figure 48. Turkey Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Chip Grade Antibodies Revenue, (US$, Mn), 2018-2029
Figure 52. Global Chip Grade Antibodies Production Capacity (Kg), 2018-2029
Figure 53. The Percentage of Production Chip Grade Antibodies by Region, 2022 VS 2029
Figure 54. Chip Grade Antibodies Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • レッドバイオテクノロジーのグローバル市場（2023年-2030年）：モノクローナル抗体、ポリクローナル抗体、ワクチン、細胞ベースの免疫療法製品、遺伝子療法製品、その他
  • 世界のカスタム抗体市場2023-2030：モノクローナル抗体、ポリクローナル抗体、リコンビナント抗体、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC12773 )"チップ用抗体のグローバル市場展望 2023年-2029年：モノクローナル抗体、ポリクローナル抗体" (英文：Chip Grade Antibodies Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。